Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 陽子線治療 | から $48,000 | から $70,000 | から $80,000 |
| 膵頭十二指腸切除術 | から $38,500 | から $23,000 | から $45,000 |
| 膵臓癌手術 | から $38,000 | から $9,000 | から $40,000 |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| ナノナイフ | から $18,500 | から $9,500 | から $25,000 |
シャロン・ペレス医師は消化管腫瘍を専門とし、ロンドンの名高いロイヤル・マーズデン癌センターで研鑽を積みました。
メリムスキー教授は膵臓癌を専門とし、スーラスキー医療センターにて数十年にわたる腫瘍学の経験を有しています。
この医師は、消化管腫瘍の治療において30年以上の経験を持つ、著名な消化器専門医です。GIがんの予防、早期診断、および治療を専門としており、Sourasky Medical CenterのCancer Prevention Centerを率いています。
ヘブライ大学で一般医学の学位を取得し、テルアビブ大学で消化器学の専門を修了したこの医師は、NewYork-Presbyterian Centerで研究を行いました。この医師は300以上の論文を発表しており、American Association for Cancer ResearchやEuropean Society of Digestive Oncologyを含む、いくつかの著名な組織のメンバーです。
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Israeli hospitals provide advanced pancreatic care including NanoKnife irreversible electroporation, which uses electrical pulses to destroy tumours near vital vessels. Centres like Sheba and Sourasky Medical Center offer robotic Whipple procedures and pioneering molecular therapies such as OncoSil microparticles for inoperable cases.
Bookimed Expert Insight: Israeli oncology centres like Sourasky and Sheba report a 90% success rate in oncology treatments through a high-volume approach. Experts such as Prof. Joseph Klauzner have over 45 years of experience in pancreatic surgery. Patients can access comprehensive diagnostic packages that include PET/CT and specialist consultations for approximately A$70,400, often leading to surgical eligibility for cases previously deemed inoperable.
Patient Consensus: Patients in Israel value the clear communication during telehealth consultations and the aggressive surgical assessments for complex cases. Many recommend sending pathology slides for a second opinion before travelling to ensure the most effective treatment plan.
Major Israeli medical centres report success rates between 85% and 90% for complex pancreatic cancer surgeries. JCI-accredited facilities maintain a 90% oncology treatment success rate overall. Specialist high-volume centres reduce procedural risks by 66% compared to smaller clinics. These outcomes include technically demanding procedures like the Whipple surgery.
Bookimed Expert Insight: Israeli oncology centres like Sourasky treat 400,000+ patients annually. This massive volume allows specialists to refine robotic techniques that improve precision during Whipple procedures. While a diagnostics-only package costs around A$5,400, surgeries like the Whipple at Sheba Medical Center typically reach A$55,200. These comprehensive packages include 14 hotel nights for recovery, which is vital for managing post-operative healing safely.
Patient Consensus: Patients note the importance of quick surgical timelines in Israel. They value clear communication during video consultations and the compassionate care provided by specialists like Dr Ofer Merimsky.
Leading medical centres in Israel for pancreatic cancer include Sheba Medical Center and Sourasky Medical Center. These JCI-accredited facilities offer multidisciplinary care. They specialise in complex Whipple procedures and advanced therapies like SIRT. Specialist teams manage diagnosis through to surgery and systemic treatments.
Bookimed Expert Insight: Israeli oncology centres show a clear specialization pattern in high-volume surgical expertise. Dr Joseph Klauzner at Sourasky has over 45 years of experience. Professor Ido Nachmany at Sheba is a Forbes-recognised specialist. This depth of experience is why these clinics maintain high success rates in complex pancreatic resections.
Patient Consensus: Patients value how quickly Israeli teams organise staging tests and multidisciplinary reviews. They highlight the kindness and professional competence of doctors during intensive treatments.
Obtaining a remote second opinion from Israeli specialists requires providing comprehensive electronic medical records, translated diagnostic reports, and uncompressed imaging files. Leading facilities like Sheba Medical Center and Sourasky Medical Center use these files to assess case suitability and determine treatment resectability before virtual consultations.
Bookimed Expert Insight: Israeli specialists often require a histopathology revision of original biopsy slides. Centres like Sourasky Medical Center serve over 400,000 patients and maintain a 90% oncology success rate. Sending physical tissue blocks early can prevent delays if the initial digital review suggests surgical options like the Whipple procedure.
Patient Consensus: Patients highlight that organizing a clear medical timeline and providing recent PET-CT scans ensures faster responses. They appreciate the professional organization of virtual meetings and the ability to ask follow-up questions in Israel.